[{"id":6148,"regimens":[{"id":11646,"duration":{"id":5690,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10942,"name":"Umifenovir","url":"cure-api2.ncats.io/v1/drugs/10942","rxNorm_id":null,"notes":null},"use_drug":[{"id":8518,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11646},{"id":8519,"answer":"In a novel combination with another drug","answer_other":"","regimen":11646}],"created":"2020-09-29T18:11:39.453483Z","updated":"2020-10-05T23:36:16.443880Z","dose":"0.2 g","frequency":"TID","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":6148},{"id":11647,"duration":{"id":5691,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8783,"name":"Lopinavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/8783","rxNorm_id":null,"notes":null},"use_drug":[{"id":8520,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11647},{"id":8521,"answer":"In a novel combination with another drug","answer_other":"","regimen":11647}],"created":"2020-09-29T18:11:39.461286Z","updated":"2020-10-05T23:36:16.400929Z","dose":"400 mg","frequency":"BD","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6148},{"id":11648,"duration":{"id":5692,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11383,"name":"Recombinant human interferon beta-2b","url":"cure-api2.ncats.io/v1/drugs/11383","rxNorm_id":null,"notes":null},"use_drug":[{"id":8522,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11648},{"id":8523,"answer":"In a novel combination with another drug","answer_other":"","regimen":11648}],"created":"2020-09-29T18:11:39.467876Z","updated":"2020-10-05T23:36:16.406764Z","dose":"5 million iu","frequency":"QD","route":"IV","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6148},{"id":11649,"duration":{"id":5693,"approximate_duration":null,"dates_unknown":false},"drug":{"id":9197,"name":"Moxifloxacin","url":"cure-api2.ncats.io/v1/drugs/9197","rxNorm_id":null,"notes":null},"use_drug":[{"id":8524,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11649},{"id":8525,"answer":"In a novel combination with another drug","answer_other":"","regimen":11649}],"created":"2020-09-29T18:11:39.473897Z","updated":"2020-10-05T23:36:16.412417Z","dose":"250 ml","frequency":"QD","route":"IV","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6148},{"id":11650,"duration":{"id":5694,"approximate_duration":null,"dates_unknown":false},"drug":{"id":9077,"name":"Methylprednisolone","url":"cure-api2.ncats.io/v1/drugs/9077","rxNorm_id":null,"notes":null},"use_drug":[{"id":8528,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11650},{"id":8529,"answer":"In a novel combination with another drug","answer_other":"","regimen":11650}],"created":"2020-09-29T18:11:39.480049Z","updated":"2020-10-05T23:36:16.417923Z","dose":"40 mg","frequency":"","route":"IV","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6148}],"site_of_infection":[],"specific_site":[],"how_outcome":[],"how_diagnosis":[{"id":13732,"answer":"Clinical assessment","answer_other":"","report":6148},{"id":13733,"answer":"Imaging","answer_other":"","report":6148},{"id":13734,"answer":"PCR","answer_other":"","report":6148}],"author_username":"Parvesh Paul","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"Christian Medical College, Ludhiana, Punjab, India.","author_country":"India","outcome_computed":"Deteriorated","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4151,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6148}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[{"id":374,"answer":"Asian","answer_other":""}],"created":"2020-09-29T18:08:45.715443Z","updated":"2020-10-05T23:36:16.386252Z","title":"A case of COVID-19 pneumonia with cerebral hemorrhage.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32505080,"doi":"10.1016/j.thromres.2020.05.050","article_url":"https://pubmed.ncbi.nlm.nih.gov/32505080/","pub_year":2020,"published_authors":"Li J\r\nLong X\r\nZhu C\r\nHu S\r\nLin Z\r\nLi J\r\nXiong N","article_author_email":"Author email could not be found.","journal":"Thrombosis research","abstract":"A 68-year-old male patient with a history of atrial fibrillation on long-term warfarin presented with fever, cough and fatigue for 8 days, associated with shortness of breath for 5 days. He was admitted on Feb 5th, 2020 [illness day 8 (iDay) 8] to Wuhan Red Cross Hospital, a hospital designated to treat patients with severe COVID-19. The patient reported that he had been in contact with confirmed COVID-19 patients. His oropharyngeal swab was tested positive for SARS-CoV-2 by reverse-transcription polymerase-chain-reaction (RT-PCR) assays. No other respiratory viral pathogens were detected. His chest CT showed bilateral multifocal ground-glass opacities, consistent with of COVID-19 pneumonia.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient died","surgery":"No","age":"61-70 years","sex":"Male","ethnicity":"Not Hispanic/Latino","country_contracted":"China","country_treated":"China","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"Atrial fibrillation","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Respiratory tract infection, somnolence","severity":null,"prev_treatment":"","unusual":"The first case to report a COVID-19 patient with a complication of cerebral hemorrhage.","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"history of atrial fibrillation on long-term warfarin presented with fever, cough and fatigue for 8 days, associated with shortness of breath for 5 days.\r\nhis warfarin was discontinued and he was started with subcutaneously treatment of low molecular weight heparin\r\nFor the treatment of cerebral hemorrhage, mannitol was given to reduce the intracranial pressure and cerebral edema. \r\nHe had progressive bilateral ground glass opacities and possible superimposed bacterial infection despite antibiotics and so these were changed to cefoperazone sulbactam (1.5 g, iv drip, qd).\r\nIntubation +\r\nHe continued to have progressive multi-organ failure with worsening respiratory failure and renal failure. After being comatose for one week, he had cardiopulmonary arrest and died on iDay 26.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[8783,9077,9197,11383,10942]}]